Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 12:57 pm Purchase | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital LLC | 2,765,530 12.5% | 74,420![]() (+2.77%) | View |
2023-02-14 11:26 am Sale | 13G | X4 Pharmaceuticals, Inc. XFOR | Ikarian Capital LLC | 349,133 0.3% | -1,915,358![]() (-84.58%) | View |
2023-02-14 11:03 am Sale | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital LLC | 460,416 1.3% | -1,289,627![]() (-73.69%) | View |
2023-02-14 11:02 am Sale | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Ikarian Capital LLC | 448,101 5.2% | -48,655![]() (-9.79%) | View |
2022-02-14 4:43 pm Sale | 13G | X4 Pharmaceuticals, Inc. XFOR | Ikarian Capital LLC | 2,264,491 8.1% | -360,497![]() (-13.73%) | View |
2022-02-14 4:41 pm Sale | 13G | aTyr Pharma, Inc. LIFE | Ikarian Capital LLC | 35,048 0.1% | -853,532![]() (-96.06%) | View |
2022-02-14 4:39 pm Sale | 13G | Protara Therapeutics, Inc. TARA | Ikarian Capital LLC | 279,256 2.5% | -370,286![]() (-57.01%) | View |
2022-02-14 4:37 pm Sale | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital LLC | 2,691,110 13.8% | -25,730![]() (-0.95%) | View |
2022-02-14 4:36 pm Sale | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital LLC | 1,750,043 5.9% | -86,502![]() (-4.71%) | View |
2022-02-14 4:36 pm Sale | 13G | Odonate, Inc. ODTC | Ikarian Capital LLC | 1,340,631 3.5% | -645,781![]() (-32.51%) | View |
2022-02-14 4:35 pm Sale | 13G | scPharmaceuticals Inc. SCPH | Ikarian Capital LLC | 901,362 3.3% | -564,785![]() (-38.52%) | View |
2022-02-14 4:34 pm Sale | 13G | Science 37 Holdings, Inc. SNCE | Ikarian Capital LLC | 0 0% | -512,450![]() (Position Closed) | View |
2022-02-14 4:34 pm Sale | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Ikarian Capital LLC | 99,422 1% | -300,578![]() (-75.14%) | View |
2022-02-14 4:32 pm Sale | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Ikarian Capital LLC | 496,756 5.9% | -3,244![]() (-0.65%) | View |
2022-02-14 4:32 pm Sale | 13G | KalVista Pharmaceuticals, Inc. KALV | Ikarian Capital LLC | 36,576 0.2% | -1,027,385![]() (-96.56%) | View |
2022-02-14 4:31 pm Sale | 13G | Tempest Therapeutics Inc. MLND | Ikarian Capital LLC | 58,803 0.9% | -1,289,218![]() (-95.64%) | View |
2022-02-14 4:30 pm Sale | 13G | Lyra Therapeutics, Inc. LYRA | Ikarian Capital LLC | 394,536 3% | -420,828![]() (-51.61%) | View |
2021-09-17 3:00 pm Purchase | 13G | aTyr Pharma, Inc. LIFE | Ikarian Capital LLC | 888,580 5.3% | 888,580![]() (New Position) | View |
2021-07-02 4:05 pm Purchase | 13G | Odonate, Inc. ODTC | Ikarian Capital LLC | 1,986,412 5.2% | 1,986,412![]() (New Position) | View |
2021-04-08 09:02 am Purchase | 13G | X4 Pharmaceuticals, Inc. XFOR | Ikarian Capital LLC | 2,624,988 11.1% | 1,798,564![]() (+217.63%) | View |